HEROHE Challenge: assessing HER2 status in breast cancer without immunohistochemistry or in situ hybridization

• URL: http://arxiv.org/abs/2111.04738v1
• Date: Mon, 8 Nov 2021 13:39:41 GMT
• Title: HEROHE Challenge: assessing HER2 status in breast cancer without immunohistochemistry or in situ hybridization
• Authors: Eduardo Conde-Sousa, Jo\~ao Vale, Ming Feng, Kele Xu, Yin Wang, Vincenzo Della Mea, David La Barbera, Ehsan Montahaei, Mahdieh Soleymani Baghshah, Andreas Turzynski, Jacob Gildenblat, Eldad Klaiman, Yiyu Hong, Guilherme Aresta, Teresa Ara\'ujo, Paulo Aguiar, Catarina Eloy, Ant\'onio Pol\'onia
• Abstract summary: HEROHE Challenge aims to automate the assessment of the HER2 status based only on hematoxylin and eosin stained tissue sample of invasive breast cancer. Methods to assess HER2 status were presented by 21 teams worldwide.
• Score: 14.8546864876007
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Breast cancer is the most common malignancy in women, being responsible for more than half a million deaths every year. As such, early and accurate diagnosis is of paramount importance. Human expertise is required to diagnose and correctly classify breast cancer and define appropriate therapy, which depends on the evaluation of the expression of different biomarkers such as the transmembrane protein receptor HER2. This evaluation requires several steps, including special techniques such as immunohistochemistry or in situ hybridization to assess HER2 status. With the goal of reducing the number of steps and human bias in diagnosis, the HEROHE Challenge was organized, as a parallel event of the 16th European Congress on Digital Pathology, aiming to automate the assessment of the HER2 status based only on hematoxylin and eosin stained tissue sample of invasive breast cancer. Methods to assess HER2 status were presented by 21 teams worldwide and the results achieved by some of the proposed methods open potential perspectives to advance the state-of-the-art.

Related papers

• Improving Breast Cancer Grade Prediction with Multiparametric MRI Created Using Optimized Synthetic Correlated Diffusion Imaging [71.91773485443125]
  Grading plays a vital role in breast cancer treatment planning. The current tumor grading method involves extracting tissue from patients, leading to stress, discomfort, and high medical costs. This paper examines using optimized CDI$s$ to improve breast cancer grade prediction.
  arXiv  Detail & Related papers  (2024-05-13T15:48:26Z)
• Using Multiparametric MRI with Optimized Synthetic Correlated Diffusion Imaging to Enhance Breast Cancer Pathologic Complete Response Prediction [71.91773485443125]
  Neoadjuvant chemotherapy has recently gained popularity as a promising treatment strategy for breast cancer. The current process to recommend neoadjuvant chemotherapy relies on the subjective evaluation of medical experts. This research investigates the application of optimized CDI$s$ to enhance breast cancer pathologic complete response prediction.
  arXiv  Detail & Related papers  (2024-05-13T15:40:56Z)
• Addressing Uncertainty in Imbalanced Histopathology Image Classification of HER2 Breast Cancer: An interpretable Ensemble Approach with Threshold Filtered Single Instance Evaluation (SIE) [0.0]
  Early diagnosis can alleviate the mortality rate by helping patients make efficient treatment decisions. HER2 has become one the most lethal subtype of Breast Cancer. DenseNet201 and Xception have been ensembled into a single classifier.
  arXiv  Detail & Related papers  (2023-08-01T19:44:31Z)
• Cancer-Net BCa-S: Breast Cancer Grade Prediction using Volumetric Deep Radiomic Features from Synthetic Correlated Diffusion Imaging [82.74877848011798]
  The prevalence of breast cancer continues to grow, affecting about 300,000 females in the United States in 2023. The gold-standard Scarff-Bloom-Richardson (SBR) grade has been shown to consistently indicate a patient's response to chemotherapy. In this paper, we study the efficacy of deep learning for breast cancer grading based on synthetic correlated diffusion (CDI$s$) imaging.
  arXiv  Detail & Related papers  (2023-04-12T15:08:34Z)
• Interpretable HER2 scoring by evaluating clinical Guidelines through a weakly supervised, constrained Deep Learning Approach [0.0]
  This paper focuses on the interpretability of HER2 scoring by a pathologist. We propose a semi-automatic, two-stage deep learning approach that directly evaluates the clinical HER2 guidelines. We achieve a performance of 0.78 in F1-score on the test set while keeping our model interpretable for the pathologist.
  arXiv  Detail & Related papers  (2022-11-17T14:28:35Z)
• Gold-standard of HER2 breast cancer biopsies using supervised learning based on multiple pathologist annotations [0.0]
  This paper presents the preliminary data analysis of the annotations of three pathologists over the same set of samples obtained using 20x magnification. We evaluate the intra- and inter-expert variability achieving substantial and moderate agreement, according to Fleiss' Kappa coefficient.
  arXiv  Detail & Related papers  (2022-11-09T02:55:20Z)
• A Pathologist-Informed Workflow for Classification of Prostate Glands in Histopathology [62.997667081978825]
  Pathologists diagnose and grade prostate cancer by examining tissue from needle biopsies on glass slides. Cancer's severity and risk of metastasis are determined by the Gleason grade, a score based on the organization and morphology of prostate cancer glands. This paper proposes an automated workflow that follows pathologists' textitmodus operandi, isolating and classifying multi-scale patches of individual glands.
  arXiv  Detail & Related papers  (2022-09-27T14:08:19Z)
• High-resolution synthesis of high-density breast mammograms: Application to improved fairness in deep learning based mass detection [48.88813637974911]
  Computer-aided detection systems based on deep learning have shown good performance in breast cancer detection. High-density breasts show poorer detection performance since dense tissues can mask or even simulate masses. This study aims to improve the mass detection performance in high-density breasts using synthetic high-density full-field digital mammograms.
  arXiv  Detail & Related papers  (2022-09-20T15:57:12Z)
• Multi-Scale Hybrid Vision Transformer for Learning Gastric Histology: AI-Based Decision Support System for Gastric Cancer Treatment [50.89811515036067]
  Gastric endoscopic screening is an effective way to decide appropriate gastric cancer (GC) treatment at an early stage, reducing GC-associated mortality rate. We propose a practical AI system that enables five subclassifications of GC pathology, which can be directly matched to general GC treatment guidance.
  arXiv  Detail & Related papers  (2022-02-17T08:33:52Z)
• Automated Scoring System of HER2 in Pathological Images under the Microscope [3.689994643251581]
  We propose a HER2 automated scoring system that strictly follows the HER2 scoring guidelines. The proposed system will be embedded in our Thorough Eye platform for deployment in hospitals.
  arXiv  Detail & Related papers  (2021-10-21T01:38:35Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.